WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology… WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSW...
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%… WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) — OptimizeRx Co...
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology… WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSW...
All Proposals Approved, Supporting Continuity of Leadership & Strategic Progress… WALTHAM, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”...
